At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- Mix of remote tasks and in-person visits
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 9 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 500
- Started
- 2025-11-01
- Last checked
- 2025-11
Plain English Summary
What is this study?
- • Testing a new treatment for overweight (bmi > 25)
- • Clinical study - 500 participants
- • We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with overweight (bmi > 25)
Where?
- • Milton Keynes - Online recruitment
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.
More detail
Despite evidence on the burden of BMI \>25, few disease-specific instruments comprehensively capture its multidimensional impact. Existing frameworks often target obesity (BMI ≥30) or patients on pharmacological or surgical therapy. Overweight and extremely obese populations are underrepresented, and economic and psychosocial dimensions are rarely integrated into severity staging. This study, therefore, aims to systematically evaluate symptoms, comorbidities, HRQoL, and costs across the full spectrum of individuals with BMI \>25, excluding those on GLP-1 therapy. Integrating clinician and patient perspectives will support the development of more inclusive severity measures and inform early intervention strategies.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Patient group
- ✓Patient is aged ≥18 years at the time of survey completion.
- ✓Patient has a BMI over 25 (self-reported)
- ✓Patient is willing to participate in all study activities.
- ✓Patient is able to read, write, and converse in English.
Who cannot take part
- ✗A participant who meets any of the following criteria will be excluded from the study:
- ✗Participants do not have the cognitive capacity to provide agreement to take part.
- ✗Participants with severe co-morbidity that might affect study participation.
See the full criteria
Where Is This Study? (1 UK site)
Online recruitment
Milton Keynes MK12 5NW, United Kingdom
How to Get in Touch
Omolade Allen, PhD
Sponsor contactCONTACT